SCHEMBL3842546

SCHEMBL3842546

O=C1C=CC2CC=CC=C2C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204611 0.73 GSK3A (0.30) GSK3AGSK3B
SCHEMBL10450111 0.69 GSK3A (0.32) GSK3AGSK3B
SCHEMBL9317021 0.68 GSK3A (0.31) GSK3AGSK3B
SCHEMBL1165259 0.66
SCHEMBL6690156 0.65 TSHR (0.39)
SCHEMBL2779617 0.64 GSK3A (0.31) GSK3AGSK3B
SCHEMBL9323751 0.64 GSK3A (0.31) GSK3AGSK3B
SCHEMBL20627543 0.64 GSK3A (0.31) GSK3AGSK3B
SCHEMBL10824454 0.63 GSK3A (0.30) GSK3AGSK3B
SCHEMBL8766748 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615613-B1 QUINOXALINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARM INC (US) 2009-11-04 EP disclosed